Evidence map›Paper›PMID 36605805›Full record

ArticleNanoscale advances2022

Acid-triggered

Ruixue Wei, Zhe Li, Bilun Kang, Gaoliang Fu, Ke Zhang, Mengzhou Xue

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ruixue WeiDepartment of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University Zhengzhou 450052 Henan China wei2009ruixue@163.com xuemengzhou@zzu.edu.cn.ORCID https://orcid.org/0000-0002-9721-3138
Zhe LiDepartment of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University Zhengzhou 450052 Henan China wei2009ruixue@163.com xuemengzhou@zzu.edu.cn.
Bilun KangState Key Laboratory of Physical Chemistry of Solid Surfaces, The MOE Laboratory of Spectrochemical Analysis & Instrumentation, The Key Laboratory for Chemical Biology of Fujian Province, College of Chemistry and Chemical Engineering, Xiamen University Xiamen 361005 Fujian China.
Gaoliang FuHenan Provincial Key Laboratory of Nanocomposites and Applications, Institute of Nanostructured Functional Materials, Huanghe Science and Technology College Zhengzhou 450006 Henan China.
Ke ZhangDepartment of Interventional Medicine, Center for Interventional Medicine, Guangdong Provincial Engineering Research Center of Molecular Imaging, Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University Zhuhai 519000 Guangdong China zhangk276@mail.sysu.edu.cn.ORCID https://orcid.org/0000-0002-1821-3640
Mengzhou XueDepartment of Cerebrovascular Diseases, The Second Affiliated Hospital of Zhengzhou University Zhengzhou 450052 Henan China wei2009ruixue@163.com xuemengzhou@zzu.edu.cn.ORCID https://orcid.org/0000-0002-4427-7285
Second Affiliated Hospital of Zhengzhou University · CNHuanghe Science and Technology College · CNSun Yat-sen University · CNXiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poor tumor delivery efficiency remains a significant challenge for the integrated nanoplatform for diagnosis and treatment. Nanotherapeutics capable of aggregation in response to the tumor microenvironment has received considerable attention because of its ability to enhance tumor delivery efficiency and accumulation. We prepared smart Au-Fe

Identifiers

PMID36605805
PMCPMC9765530
OpenAlexW4313380181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.